Skip to main content
Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.98
+0.08 (1.01%)
Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2005 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Gyre Pharmaceuticals
105.76M
Log In
Log In
Log In
Log In
Upgrade
Gyre Pharmaceuticals Growth
-6.78%
Log In
Log In
Log In
Log In
Upgrade
Protease Engineering
-
Log In
Log In
Log In
Log In
Upgrade
Protease Engineering Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2005 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
China
105.76M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-6.78%
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-
Log In
Log In
Log In
Log In
Upgrade